These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16258211)

  • 1. Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
    Tohyama T; Matsui K; Kitagawa K
    Intern Med; 2005 Sep; 44(9):958-62. PubMed ID: 16258211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
    Massimino K; Harrskog O; Pommier S; Pommier R
    J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
    Katakami N; Matsumoto H; Ishihara K; Umeda B
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete histological regression of metastatic carcinoid tumour after treatment with octreotide.
    Imtiaz KE; Monteith P; Khaleeli A
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):755-8. PubMed ID: 11155099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy.
    Khan MQ; Al Kahtani KM; Al-Ashgar H
    Ann Saudi Med; 2004; 24(5):386-90. PubMed ID: 15573856
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
    Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
    Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome.
    Majeed F; Porter TR; Tarantolo S; Duhachek-Stapelman A; Xie F; Elhendy A
    Eur J Echocardiogr; 2007 Oct; 8(5):386-9. PubMed ID: 17011239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.
    Siu LL; Chapman W; Moore MJ
    Am J Clin Oncol; 1997 Dec; 20(6):558-61. PubMed ID: 9391539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary ovarian carcinoid tumor in combination with carcinoid heart disease; a case report.
    Oei SG; Kloosterman MD; Verhoeven AT
    Eur J Obstet Gynecol Reprod Biol; 1989 May; 31(2):185-8. PubMed ID: 2759325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of carcinoid tumor].
    Elizalde I; Borda F
    Gastroenterol Hepatol; 2002 Oct; 25(8):508-13. PubMed ID: 12361534
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of liver metastases of carcinoid tumors.
    Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
    World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analogs of somatostatin and carcinoid tumors].
    Gutiérrez Rodero F; Morales Cano JM; de Blas Laborda C; González Barber A
    Med Clin (Barc); 1990 Jun; 95(2):78-9. PubMed ID: 2250512
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic carcinoid disease inducing coronary vasospasm.
    Eapen DJ; Clements S; Block P; Sperling L
    Tex Heart Inst J; 2012; 39(1):76-8. PubMed ID: 22412234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging diagnosis of carcinoid heart disease.
    Bastarrika G; Cao MG; Cano D; Barba J; de Buruaga JD
    J Comput Assist Tomogr; 2005; 29(6):756-9. PubMed ID: 16272847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoid heart disease in an elderly female patient: the value of transthoracic echocardiography.
    Stougiannos P; Michas G; Evdoridis C; Arapantoni-Dadioti P; Tolios P; Kaplanis I; Trikas A
    Hellenic J Cardiol; 2017; 58(1):65-68. PubMed ID: 28163144
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.
    Molenaar JP; Baten A; Blokx WA; Hoogendam A
    Eur Urol; 2009 Nov; 56(5):874-7; quiz 876. PubMed ID: 19171417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
    Pavel ME; Hainsworth JD; Baudin E; Peeters M; Hörsch D; Winkler RE; Klimovsky J; Lebwohl D; Jehl V; Wolin EM; Öberg K; Van Cutsem E; Yao JC;
    Lancet; 2011 Dec; 378(9808):2005-2012. PubMed ID: 22119496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR inhibitor therapy for patients with carcinoid.
    Rindi G; Caplin M
    Lancet; 2011 Dec; 378(9808):1978-1980. PubMed ID: 22119494
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare case of intra-cardiac metastasis from an appendiceal carcinoid tumour without liver metastases.
    Patel S; Heetun M; Gurjar SV; Szakacs S
    Int J Colorectal Dis; 2009 Aug; 24(8):993-4. PubMed ID: 19387658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.